Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 5
1973 1
1974 2
1976 1
1982 1
1983 1
1987 2
1988 3
1989 1
1993 1
1995 1
1999 2
2000 2
2002 2
2003 5
2004 1
2005 12
2006 6
2007 17
2008 27
2009 22
2010 31
2011 41
2012 55
2013 45
2014 49
2015 55
2016 48
2017 36
2018 40
2019 32
2020 38
2021 71
2022 87
2023 26
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

670 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Among authors: cha e. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.
Coleman JA, Yip W, Wong NC, Sjoberg DD, Bochner BH, Dalbagni G, Donat SM, Herr HW, Cha EK, Donahue TF, Pietzak EJ, Hakimi AA, Kim K, Al-Ahmadie HA, Vargas HA, Alvim RG, Ghafoor S, Benfante NE, Meraney AM, Shichman SJ, Kamradt JM, Nair SG, Baccala AA Jr, Palyca P, Lash BW, Rizvi MA, Swanson SK, Muina AF, Apolo AB, Iyer G, Rosenberg JE, Teo MY, Bajorin DF. Coleman JA, et al. Among authors: cha ek. J Clin Oncol. 2023 Mar 10;41(8):1618-1625. doi: 10.1200/JCO.22.00763. Epub 2023 Jan 5. J Clin Oncol. 2023. PMID: 36603175 Free PMC article. Clinical Trial.
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.
Kluger HM, Tawbi HA, Ascierto ML, Bowden M, Callahan MK, Cha E, Chen HX, Drake CG, Feltquate DM, Ferris RL, Gulley JL, Gupta S, Humphrey RW, LaVallee TM, Le DT, Hubbard-Lucey VM, Papadimitrakopoulou VA, Postow MA, Rubin EH, Sharon E, Taube JM, Topalian SL, Zappasodi R, Sznol M, Sullivan RJ. Kluger HM, et al. Among authors: cha e. J Immunother Cancer. 2020 Mar;8(1):e000398. doi: 10.1136/jitc-2019-000398. J Immunother Cancer. 2020. PMID: 32238470 Free PMC article.
Reply by Authors.
Almassi N, Cha EK, Vertosick EA, Huang C, Wong N, Dason S, McPherson V, Dean L, Benfante N, Sjoberg DD, Rosenberg JE, Bajorin DF, Herr HW, Dalbagni G, Bochner BH. Almassi N, et al. Among authors: cha ek. J Urol. 2020 Oct;204(4):684. doi: 10.1097/JU.0000000000001071.03. Epub 2020 Jul 23. J Urol. 2020. PMID: 32701382 No abstract available.
Transanal Surgery: A History of taTME Ancestry.
Izquierdo KM, Salem JF, Cha E, Unal E, Marks JH. Izquierdo KM, et al. Among authors: cha e. Clin Colon Rectal Surg. 2020 May;33(3):128-133. doi: 10.1055/s-0039-1698395. Epub 2019 Nov 7. Clin Colon Rectal Surg. 2020. PMID: 32351335 Free PMC article. Review.
Anisakiasis in Palatine Tonsil.
Cha EJ, Kim JS, Heo SJ. Cha EJ, et al. J Craniofac Surg. 2022 Oct 1;33(7):e692-e694. doi: 10.1097/SCS.0000000000008580. Epub 2022 Feb 17. J Craniofac Surg. 2022. PMID: 35184111
PD-L1 inhibition with MPDL3280A for solid tumors.
Cha E, Wallin J, Kowanetz M. Cha E, et al. Semin Oncol. 2015 Jun;42(3):484-7. doi: 10.1053/j.seminoncol.2015.02.002. Epub 2015 Feb 12. Semin Oncol. 2015. PMID: 25965367 Review.
Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne.
Nison L, Colin P, Remzi M, Shariat S, Klatte T, Yakoubi R, Bozzini G, Capitanio U, Babjuk M, Merseburger A, Cha E, Fritsche H, Novara G, Montorsi F, Hora M, Roupret M. Nison L, et al. Among authors: cha e. Prog Urol. 2015 Nov;25(13):807. doi: 10.1016/j.purol.2015.08.182. Prog Urol. 2015. PMID: 26544377 French. No abstract available.
670 results